Axenoll 3D Printing Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$8.26M
- Investors
-
1
Axenoll 3D Printing General Information
Description
Developer of 3D printing biomaterials machine intended for use in the medical and biotechnological sectors. The company specializes in the global licensing rights for cellular and molecular 3D bioprinting in the context of clean room research and development, production, and marketing based on the patented expertise of 3D mass customization, enabling customers' research and development consulting and OEM production to meet better standards.
Contact Information
Website
www.axenoll.comCorporate Office
- Otto-Schott-Straße 15
- 07745 Jena
- Germany
Corporate Office
- Otto-Schott-Straße 15
- 07745 Jena
- Germany
Axenoll 3D Printing Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 29-Jul-2021 | $8.26M | Completed | Generating Revenue |
Axenoll 3D Printing Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | 1,472,100 | $2.72 | $2.72 | 1x | $2.72 | 11.39% |
Axenoll 3D Printing Patents
Axenoll 3D Printing Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4201439-A1 | A three-dimensional biocompatible matrix and its uses in wound management | Pending | 23-Dec-2021 | ||
| EP-4452349-A1 | A three-dimensional biocompatible matrix and its uses in wound management | Pending | 23-Dec-2021 | ||
| US-20250058025-A1 | A three-dimensional biocompatible matrix and its uses in wound management | Pending | 23-Dec-2021 | ||
| WO-2023118589-A1 | A three-dimensional biocompatible matrix and its uses in wound management | Inactive | 23-Dec-2021 | ||
| JP-2024546315-A | Three-dimensional biocompatible matrices and their use in wound management - patents.com | Pending | 23-Dec-2021 | A61L27/60 |
Axenoll 3D Printing Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Xlife Sciences | Venture Capital | Minority |
Axenoll 3D Printing FAQs
-
When was Axenoll 3D Printing founded?
Axenoll 3D Printing was founded in 2014.
-
Where is Axenoll 3D Printing headquartered?
Axenoll 3D Printing is headquartered in Jena, Germany.
-
What industry is Axenoll 3D Printing in?
Axenoll 3D Printing’s primary industry is Other Commercial Services.
-
Is Axenoll 3D Printing a private or public company?
Axenoll 3D Printing is a Private company.
-
What is the current valuation of Axenoll 3D Printing?
The current valuation of Axenoll 3D Printing is .
-
What is Axenoll 3D Printing’s current revenue?
The current revenue for Axenoll 3D Printing is .
-
How much funding has Axenoll 3D Printing raised over time?
Axenoll 3D Printing has raised $8.26M.
-
Who are Axenoll 3D Printing’s investors?
Xlife Sciences has invested in Axenoll 3D Printing.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process